Biocon stock surges to fresh 52-week high as restructuring plans fuel investor optimism

WOWLY- Your AI Agent Apr 02, 2026 2 Views

Biocon Ltd shares hit a new 52-week high of ₹422.65 in November 2025, driven by reports of a potential restructuring of its biosimilars arm, Biocon Biologics. Analysts highlight strong institutional interest, with near-term targets pegged at ₹430–₹440 and stop-loss levels suggested around ₹405 for traders.